Home

Vimta Labs Ltd EPS

Image

Vimta Labs Ltd

NSE: VIMTALABS

EPS

₹ 27.37

Last updated on: Feb 04, 2025

Key Highlights

  • The Earning per Share of Vimta Labs Ltd is ₹ 27.37 as of 04 Feb 25 .
  • The earning per share of Vimta Labs Ltd changed from ₹ 5.51 to ₹ 9.65 over 7 quarters. This represents a CAGR of 37.74% .

Historical Earning per Share of Vimta Labs Ltd

No data available

* All values are in

Company Fundamentals for Vimta Labs Ltd

Market Cap

1,870 Cr

EPS

27.4

P/E Ratio (TTM)

30.8

P/B Ratio (TTM)

5.5

Day’s High

952.0

Day’s Low

841.6

DTE

0.0

ROE

14.6

52 Week High

1070.55

52 Week Low

420.0

ROCE

19.0

Market Price of Vimta Labs Ltd

1M

1Y

3Y

5Y

Monitoring Vimta Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Feb 2025842.2
03 Feb 2025848.2
01 Feb 2025876.55
31 Jan 2025854.75
30 Jan 2025833.15
29 Jan 2025851.05
28 Jan 2025798.55
27 Jan 2025833.8
24 Jan 2025867.85
23 Jan 2025865.7

SWOT Analysis Of Vimta Labs Ltd

Strength

6

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Vimta Labs Ltd

Asset Value vs Market Value of Vimta Labs Ltd

Market Value

1,871

Asset Value

Value addition

10.3 X

165

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Vimta Labs Ltd1870
Max Healthcare Institute Ltd114075
Apollo Hospitals Enterprise Ltd97797
Fortis Healthcare Ltd47487
Syngene International Ltd29784
Global Health Ltd27942

Historical Market Cap of Vimta Labs Ltd

No data available

* All values are in crore

Historical Revenue of Vimta Labs Ltd

No data available

* All values are in crore

Historical EBITDA of Vimta Labs Ltd

No data available

* All values are in crore

Historical Net Profit of Vimta Labs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Vimta Labs Ltd News Hub

Vimta Labs completes sale of its diagnostic and pathological services business

Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business

Read more

11 Oct 24

Vimta Labs to hold board meeting

Vimta Labs will hold a meeting of the Board of Directors of the Company on 8 November 2024 Powered b

Read more

05 Nov 24

Vimta Labs consolidated net profit rises 140.92% in the September 2024 quarter

Net profit of Vimta Labs rose 140.92% to Rs 15.25 crore in the quarter ended September 2024 as again

Read more

08 Nov 24

Vimta Labs consolidated net profit rises 112.24% in the December 2024 quarter

Net profit of Vimta Labs rose 112.24% to Rs 21.50 crore in the quarter ended December 2024 as agains

Read more

24 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Vimta Labs Ltd

What is the EPS of Vimta Labs Ltd stock?

The Earnings Per Share (EPS) of Vimta Labs Ltd is 27.37. An EPS is the amount of net income attributed to each share of a common stock.

How is Vimta Labs Ltd EPS calculated?

The EPS of Vimta Labs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Vimta Labs Ltd report its EPS?

Vimta Labs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Vimta Labs Ltd EPS?

Factors that influence the EPS of Vimta Labs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Vimta Labs Ltd EPS growth indicate future performance?

Yes, consistent growth in Vimta Labs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions